Follow The Filings

ANIP Ani Pharmaceuticals Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 exit

ANIP (Ani Pharmaceuticals Inc.) 13F ownership among featured managers we track as of 2026 Q2. In 2026 Q2 filings, 1 manager sold out. Figures are as-filed 13F, not free float.

Who owns ANIP

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Polen Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 6,409 $493K History

0 current · 1 exited last period · options excluded

Insider trades

Open-market buys and sales by ANIP's executives, directors and 10% owners, from their Form 4s · last 12 months

All ANIP insider trades →
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $208K sold by 1 insider under 10b5-1 plans
  1. Stephen P. Carey CFO
    Planned sale
    $208K 2,850 shares at $73.00 1.7% of stake
    Traded Sep 29 Filed Sep 30
    ↗

SEC filings

Recent issuer filings from EDGAR · 9 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 4.01,9.01 Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $486.82M $614.38M $883.37M
Net income $18.78M -$18.52M $78.34M
Net margin * 3.9% -3.0% 8.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $519.82M $527.68M $753.12M
Total non-current assets * $384.61M $756.01M $687.26M
Total assets $0.904B $1.28B $1.44B
Total current liabilities $145.48M $193.68M $278.11M
Total non-current liabilities * $301.35M $661.49M $621.54M
Total equity $432.75M $403.68M $540.72M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $118.96M $64.02M $185.22M
Cash from investing -$18.51M -$404.72M -$34.32M
Cash from financing $67.44M $264.94M -$9.94M
Net change in cash $167.89M -$76.23M $140.73M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow The Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders